nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00358	0.0885	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00353	0.0871	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00353	0.0871	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00348	0.0859	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00345	0.0851	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00342	0.0846	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.00342	0.0846	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00334	0.0826	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.00327	0.0808	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00319	0.0789	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.00317	0.0784	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.0031	0.0765	CbGdCrCtD
Fludarabine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00269	0.0028	CcSEcCtD
Fludarabine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00265	0.00276	CcSEcCtD
Fludarabine—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00264	0.00276	CcSEcCtD
Fludarabine—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00264	0.00275	CcSEcCtD
Fludarabine—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00263	0.00274	CcSEcCtD
Fludarabine—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00262	0.00274	CcSEcCtD
Fludarabine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00262	0.00273	CcSEcCtD
Fludarabine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00262	0.00273	CcSEcCtD
Fludarabine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00261	0.00272	CcSEcCtD
Fludarabine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00261	0.00272	CcSEcCtD
Fludarabine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00261	0.00272	CcSEcCtD
Fludarabine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00261	0.00272	CcSEcCtD
Fludarabine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00261	0.00272	CcSEcCtD
Fludarabine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.00256	0.00267	CcSEcCtD
Fludarabine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00256	0.00266	CcSEcCtD
Fludarabine—Sweating increased—Prednisone—ankylosing spondylitis	0.00253	0.00264	CcSEcCtD
Fludarabine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00253	0.00264	CcSEcCtD
Fludarabine—Neutropenia—Prednisone—ankylosing spondylitis	0.00243	0.00253	CcSEcCtD
Fludarabine—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.0024	0.0025	CcSEcCtD
Fludarabine—Haemoglobin—Betamethasone—ankylosing spondylitis	0.0024	0.0025	CcSEcCtD
Fludarabine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00239	0.00249	CcSEcCtD
Fludarabine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00239	0.00249	CcSEcCtD
Fludarabine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00235	0.00245	CcSEcCtD
Fludarabine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00234	0.00244	CcSEcCtD
Fludarabine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00234	0.00244	CcSEcCtD
Fludarabine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00232	0.00242	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00231	0.00241	CcSEcCtD
Fludarabine—Visual impairment—Betamethasone—ankylosing spondylitis	0.0023	0.0024	CcSEcCtD
Fludarabine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0023	0.0024	CcSEcCtD
Fludarabine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00228	0.00238	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00228	0.00238	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00227	0.00237	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00227	0.00237	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00226	0.00236	CcSEcCtD
Fludarabine—Malaise—Prednisolone—ankylosing spondylitis	0.00225	0.00234	CcSEcCtD
Fludarabine—Convulsion—Prednisolone—ankylosing spondylitis	0.00216	0.00225	CcSEcCtD
Fludarabine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00213	0.00222	CcSEcCtD
Fludarabine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00213	0.00222	CcSEcCtD
Fludarabine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00212	0.00221	CcSEcCtD
Fludarabine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00212	0.00221	CcSEcCtD
Fludarabine—Alopecia—Betamethasone—ankylosing spondylitis	0.00211	0.0022	CcSEcCtD
Fludarabine—Alopecia—Dexamethasone—ankylosing spondylitis	0.00211	0.0022	CcSEcCtD
Fludarabine—Discomfort—Prednisolone—ankylosing spondylitis	0.00209	0.00218	CcSEcCtD
Fludarabine—Haemoglobin—Prednisone—ankylosing spondylitis	0.00209	0.00218	CcSEcCtD
Fludarabine—Haemorrhage—Prednisone—ankylosing spondylitis	0.00208	0.00217	CcSEcCtD
Fludarabine—Malaise—Triamcinolone—ankylosing spondylitis	0.00206	0.00215	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00206	0.00215	CcSEcCtD
Fludarabine—Malaise—Methylprednisolone—ankylosing spondylitis	0.00206	0.00215	CcSEcCtD
Fludarabine—Oedema—Prednisolone—ankylosing spondylitis	0.00203	0.00212	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00203	0.00212	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—ankylosing spondylitis	0.00203	0.00211	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00203	0.00211	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00202	0.0021	CcSEcCtD
Fludarabine—Cough—Triamcinolone—ankylosing spondylitis	0.002	0.00208	CcSEcCtD
Fludarabine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00198	0.00207	CcSEcCtD
Fludarabine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00198	0.00206	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00196	0.00205	CcSEcCtD
Fludarabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00195	0.00203	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.00195	0.00203	CcSEcCtD
Fludarabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00195	0.00203	CcSEcCtD
Fludarabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00195	0.00203	CcSEcCtD
Fludarabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00193	0.00201	CcSEcCtD
Fludarabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00193	0.00201	CcSEcCtD
Fludarabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00193	0.00201	CcSEcCtD
Fludarabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00192	0.002	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00192	0.002	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—ankylosing spondylitis	0.0019	0.00198	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.00189	0.00197	CcSEcCtD
Fludarabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00188	0.00196	CcSEcCtD
Fludarabine—Malaise—Dexamethasone—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Fludarabine—Malaise—Betamethasone—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Fludarabine—Oedema—Triamcinolone—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Fludarabine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Fludarabine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00186	0.00194	CcSEcCtD
Fludarabine—Arrhythmia—Prednisone—ankylosing spondylitis	0.00186	0.00194	CcSEcCtD
Fludarabine—Infection—Triamcinolone—ankylosing spondylitis	0.00186	0.00193	CcSEcCtD
Fludarabine—Infection—Methylprednisolone—ankylosing spondylitis	0.00185	0.00193	CcSEcCtD
Fludarabine—Haematuria—Methotrexate—ankylosing spondylitis	0.00184	0.00192	CcSEcCtD
Fludarabine—Alopecia—Prednisone—ankylosing spondylitis	0.00184	0.00191	CcSEcCtD
Fludarabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00183	0.00191	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.00183	0.0019	CcSEcCtD
Fludarabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00182	0.0019	CcSEcCtD
Fludarabine—Malnutrition—Prednisone—ankylosing spondylitis	0.00181	0.00189	CcSEcCtD
Fludarabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00181	0.00188	CcSEcCtD
Fludarabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0018	0.00188	CcSEcCtD
Fludarabine—Convulsion—Dexamethasone—ankylosing spondylitis	0.0018	0.00188	CcSEcCtD
Fludarabine—Convulsion—Betamethasone—ankylosing spondylitis	0.0018	0.00188	CcSEcCtD
Fludarabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00177	0.00184	CcSEcCtD
Fludarabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00177	0.00184	CcSEcCtD
Fludarabine—Discomfort—Betamethasone—ankylosing spondylitis	0.00175	0.00182	CcSEcCtD
Fludarabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00175	0.00182	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00175	0.00182	CcSEcCtD
Fludarabine—Pain—Prednisolone—ankylosing spondylitis	0.00174	0.00181	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00174	0.00181	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00172	0.0018	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Oedema—Dexamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Oedema—Betamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Fludarabine—Infection—Betamethasone—ankylosing spondylitis	0.00168	0.00176	CcSEcCtD
Fludarabine—Infection—Dexamethasone—ankylosing spondylitis	0.00168	0.00176	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00168	0.00175	CcSEcCtD
Fludarabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00168	0.00175	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00167	0.00175	CcSEcCtD
Fludarabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00167	0.00174	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00167	0.00174	CcSEcCtD
Fludarabine—Anaemia—Prednisone—ankylosing spondylitis	0.00167	0.00174	CcSEcCtD
Fludarabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00167	0.00174	CcSEcCtD
Fludarabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00166	0.00173	CcSEcCtD
Fludarabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00166	0.00173	CcSEcCtD
Fludarabine—Agitation—Prednisone—ankylosing spondylitis	0.00166	0.00173	CcSEcCtD
Fludarabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00166	0.00173	CcSEcCtD
Fludarabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00166	0.00173	CcSEcCtD
Fludarabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00164	0.00171	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00164	0.00171	CcSEcCtD
Fludarabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00164	0.00171	CcSEcCtD
Fludarabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00164	0.00171	CcSEcCtD
Fludarabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00164	0.00171	CcSEcCtD
Fludarabine—Malaise—Prednisone—ankylosing spondylitis	0.00163	0.0017	CcSEcCtD
Fludarabine—Anorexia—Betamethasone—ankylosing spondylitis	0.00162	0.00168	CcSEcCtD
Fludarabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00162	0.00168	CcSEcCtD
Fludarabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00161	0.00168	CcSEcCtD
Fludarabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00161	0.00168	CcSEcCtD
Fludarabine—Pain—Triamcinolone—ankylosing spondylitis	0.0016	0.00167	CcSEcCtD
Fludarabine—Convulsion—Prednisone—ankylosing spondylitis	0.00157	0.00163	CcSEcCtD
Fludarabine—Chills—Methotrexate—ankylosing spondylitis	0.00156	0.00162	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00154	0.00161	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00154	0.00161	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—ankylosing spondylitis	0.00154	0.00161	CcSEcCtD
Fludarabine—Myalgia—Prednisone—ankylosing spondylitis	0.00154	0.00161	CcSEcCtD
Fludarabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00154	0.0016	CcSEcCtD
Fludarabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00154	0.0016	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—ankylosing spondylitis	0.00153	0.0016	CcSEcCtD
Fludarabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00152	0.00159	CcSEcCtD
Fludarabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00152	0.00159	CcSEcCtD
Fludarabine—Discomfort—Prednisone—ankylosing spondylitis	0.00152	0.00159	CcSEcCtD
Fludarabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00151	0.00158	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0015	0.00156	CcSEcCtD
Fludarabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00149	0.00156	CcSEcCtD
Fludarabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00149	0.00156	CcSEcCtD
Fludarabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00148	0.00154	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00148	0.00154	CcSEcCtD
Fludarabine—Oedema—Prednisone—ankylosing spondylitis	0.00148	0.00154	CcSEcCtD
Fludarabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Fludarabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Fludarabine—Infection—Prednisone—ankylosing spondylitis	0.00147	0.00153	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00146	0.00153	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00146	0.00153	CcSEcCtD
Fludarabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00146	0.00152	CcSEcCtD
Fludarabine—Fatigue—Betamethasone—ankylosing spondylitis	0.00146	0.00152	CcSEcCtD
Fludarabine—Pain—Betamethasone—ankylosing spondylitis	0.00145	0.00151	CcSEcCtD
Fludarabine—Pain—Dexamethasone—ankylosing spondylitis	0.00145	0.00151	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00145	0.00151	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00143	0.00149	CcSEcCtD
Fludarabine—Anorexia—Prednisone—ankylosing spondylitis	0.00141	0.00147	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0014	0.00146	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—ankylosing spondylitis	0.0014	0.00146	CcSEcCtD
Fludarabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0014	0.00146	CcSEcCtD
Fludarabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0014	0.00146	CcSEcCtD
Fludarabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00138	0.00143	CcSEcCtD
Fludarabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00137	0.00143	CcSEcCtD
Fludarabine—Malaise—Methotrexate—ankylosing spondylitis	0.00136	0.00142	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00135	0.00141	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00135	0.0014	CcSEcCtD
Fludarabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00134	0.0014	CcSEcCtD
Fludarabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00134	0.0014	CcSEcCtD
Fludarabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00134	0.0014	CcSEcCtD
Fludarabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00134	0.00139	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00133	0.00138	CcSEcCtD
Fludarabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00132	0.00138	CcSEcCtD
Fludarabine—Cough—Methotrexate—ankylosing spondylitis	0.00132	0.00138	CcSEcCtD
Fludarabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00132	0.00137	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—ankylosing spondylitis	0.00131	0.00137	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.0013	0.00135	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00129	0.00134	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—ankylosing spondylitis	0.00129	0.00134	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Fludarabine—Rash—Prednisolone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Fludarabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00128	0.00133	CcSEcCtD
Fludarabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00128	0.00133	CcSEcCtD
Fludarabine—Fatigue—Prednisone—ankylosing spondylitis	0.00127	0.00133	CcSEcCtD
Fludarabine—Headache—Prednisolone—ankylosing spondylitis	0.00127	0.00133	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—ankylosing spondylitis	0.00127	0.00133	CcSEcCtD
Fludarabine—Constipation—Prednisone—ankylosing spondylitis	0.00126	0.00132	CcSEcCtD
Fludarabine—Confusional state—Methotrexate—ankylosing spondylitis	0.00124	0.0013	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00123	0.00129	CcSEcCtD
Fludarabine—Infection—Methotrexate—ankylosing spondylitis	0.00123	0.00128	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00122	0.00127	CcSEcCtD
Fludarabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00122	0.00127	CcSEcCtD
Fludarabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00122	0.00127	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00126	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00121	0.00126	CcSEcCtD
Fludarabine—Nausea—Prednisolone—ankylosing spondylitis	0.00121	0.00126	CcSEcCtD
Fludarabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.0012	0.00125	CcSEcCtD
Fludarabine—Pruritus—Betamethasone—ankylosing spondylitis	0.0012	0.00125	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00119	0.00124	CcSEcCtD
Fludarabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00119	0.00124	CcSEcCtD
Fludarabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00119	0.00124	CcSEcCtD
Fludarabine—Rash—Triamcinolone—ankylosing spondylitis	0.00118	0.00123	CcSEcCtD
Fludarabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00118	0.00123	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—ankylosing spondylitis	0.00118	0.00123	CcSEcCtD
Fludarabine—Rash—Methylprednisolone—ankylosing spondylitis	0.00118	0.00123	CcSEcCtD
Fludarabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00117	0.00122	CcSEcCtD
Fludarabine—Headache—Triamcinolone—ankylosing spondylitis	0.00117	0.00122	CcSEcCtD
Fludarabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00117	0.00122	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00117	0.00122	CcSEcCtD
Fludarabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00116	0.00121	CcSEcCtD
Fludarabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00116	0.00121	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00112	0.00117	CcSEcCtD
Fludarabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00111	0.00116	CcSEcCtD
Fludarabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00111	0.00115	CcSEcCtD
Fludarabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00111	0.00115	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0011	0.00115	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00109	0.00113	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00109	0.00113	CcSEcCtD
Fludarabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00108	0.00112	CcSEcCtD
Fludarabine—Vomiting—Betamethasone—ankylosing spondylitis	0.00108	0.00112	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Fludarabine—Rash—Dexamethasone—ankylosing spondylitis	0.00107	0.00111	CcSEcCtD
Fludarabine—Rash—Betamethasone—ankylosing spondylitis	0.00107	0.00111	CcSEcCtD
Fludarabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00107	0.00111	CcSEcCtD
Fludarabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00107	0.00111	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00107	0.00111	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—ankylosing spondylitis	0.00106	0.00111	CcSEcCtD
Fludarabine—Headache—Betamethasone—ankylosing spondylitis	0.00106	0.00111	CcSEcCtD
Fludarabine—Headache—Dexamethasone—ankylosing spondylitis	0.00106	0.00111	CcSEcCtD
Fludarabine—Asthenia—Prednisone—ankylosing spondylitis	0.00106	0.0011	CcSEcCtD
Fludarabine—Pain—Methotrexate—ankylosing spondylitis	0.00106	0.0011	CcSEcCtD
Fludarabine—Pruritus—Prednisone—ankylosing spondylitis	0.00104	0.00109	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00102	0.00106	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00101	0.00105	CcSEcCtD
Fludarabine—Nausea—Betamethasone—ankylosing spondylitis	0.00101	0.00105	CcSEcCtD
Fludarabine—Nausea—Dexamethasone—ankylosing spondylitis	0.00101	0.00105	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000976	0.00102	CcSEcCtD
Fludarabine—Vomiting—Prednisone—ankylosing spondylitis	0.000939	0.000978	CcSEcCtD
Fludarabine—Rash—Prednisone—ankylosing spondylitis	0.000931	0.00097	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—ankylosing spondylitis	0.00093	0.000969	CcSEcCtD
Fludarabine—Headache—Prednisone—ankylosing spondylitis	0.000925	0.000964	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000909	0.000948	CcSEcCtD
Fludarabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000885	0.000923	CcSEcCtD
Fludarabine—Nausea—Prednisone—ankylosing spondylitis	0.000877	0.000914	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000873	0.00091	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000844	0.00088	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000785	0.000818	CcSEcCtD
Fludarabine—Rash—Methotrexate—ankylosing spondylitis	0.000778	0.000811	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000777	0.00081	CcSEcCtD
Fludarabine—Headache—Methotrexate—ankylosing spondylitis	0.000773	0.000806	CcSEcCtD
Fludarabine—Nausea—Methotrexate—ankylosing spondylitis	0.000733	0.000764	CcSEcCtD
